Journal profile · Medicine-Dermatology
Dermatology and Therapy
ISSN 2193-8210 · eISSN 2190-9172 · Springer Healthcare · Germany · 12 issues per year · Founded 2011
Dermatology and Therapy: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4.61; fully open access; APC about USD 7,675; median 61 days to acceptance (120 articles, last 24 months); 303 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Dermatology and Therapy is published by Springer Healthcare and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases and Spondyloarthritis Studies and Treatments, together about 46.6% of its articles. Its main subfields are Dermatology. (generated from OpenAlex topic counts and CAS ranking data)
Aims and Scope Dermatology and Therapy is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3–4 weeks from acceptance). The journal is dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of dermatological therapies. Studies relating to diagnosis, pharmacoeconomics, public health and epidemiology, quality of life, and patient care, management, and education are also encouraged. Areas of focus include, but are not limited to all clinical aspects of dermatology, such as skin pharmacology; skin development and aging; prevention, diagnosis, and management of skin disorders and melanomas; research into dermal structures and pathology; and all areas of aesthetic dermatology, including skin maintenance, dermatological surgery, and lasers. The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports/case series, trial protocols, and short communications. Dermatology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an International and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of quality research, which may be considered of insufficient interest by other journals. The journal appeals to a global audience and receives submissions from all over the world. Rapid Publication The journal aims for a 2-week peer review, and 3-4 weeks from acceptance to online. Please note that for any steps outside of our standard publication processes, such as multiple rounds of peer review or article proofs, or non-standard copyright requests, this may delay publication beyond these timelines. Personal Service The journal's dedicated in-house editorial team offer a personal 'concierge service' meaning authors will always have an editorial contact able to update them on the status of their manuscript. The editorial team check all manuscripts to ensure that they conform to the journal's submission guidelines. This supports the publication of ethically sound and transparent research. Digital Features and Plain Language Summaries Dermatology and Therapy offers
From the journal's Aims & Scope
Research area (LetPub): Medicine-Dermatology
Editor-in-chief Alan MenterPublisher website
Editorial board by country: none in mainland China; most named United States 40, Italy 28, Spain 14, Germany 9, Brazil 7 (140 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Psoriasis: Treatment and PathogenesisImmunology and Microbiology19.6%
- Dermatology and Skin DiseasesMedicine18.1%
- Spondyloarthritis Studies and TreatmentsMedicine9%
- Acne and Rosacea Treatments and EffectsMedicine5.7%
- Dermatologic Treatments and ResearchMedicine4.2%
- Skin Protection and AgingMedicine4%
- Hair Growth and DisordersMedicine3.9%
- Hidradenitis Suppurativa and TreatmentsMedicine3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Dermatology | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Dermatology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Dermatology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbaseCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.61LetPub ·
- Impact factor (publisher) 2025
- 4.6Publisher website ·
- 5-year impact factor (publisher) 2025
- 4.5Publisher website ·
- CiteScore 2026-06
- 7.3LetPub ·
- SJR 2026-06
- 1.6LetPub ·
- SNIP 2026-06
- 1.59LetPub ·
- h-index
- 72OpenAlex ·
- i10-index
- 794OpenAlex ·
- 2-year mean citedness
- 4OpenAlex ·
- Self-citation rate
- 8.7%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 276LetPub ·
- Downloads per year (publisher) 2025
- 2,300,000Publisher website ·
Articles by year OpenAlex count · 1,900 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 280 | 280 | 129 |
| 2025 | 303 | 303 | 1,177 |
| 2024 | 239 | 239 | 1,985 |
| 2023 | 197 | 197 | 3,200 |
| 2022 | 215 | 215 | 3,846 |
| 2021 | 185 | 185 | 4,099 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
61 daysMedian, submission to acceptance · P25–P75 41 days – 79 days
- Acceptance to online
- median 23 days (120 articles)
- Submission to online
- median 82 days
- Sample
- 120 articles with submission and acceptance dates (629 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 6 weeksLetPub ·
- Submission to first decision
- 4 daysPublisher website ·
- Acceptance to publication
- 28 daysPublisher website ·
- Submission to publication (journal-reported)
- about 6 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 5,950 / USD 7,675 / GBP 5,120 | Yes | CC BY-NC | |
| OpenAlex | USD 7,400 / EUR 5,750 / GBP 4,900 | — | — | |
| LetPub | GBP 4,700 / USD 6,850 / EUR 5,500 | Yes | — | |
| Publisher website | EUR 5,950 / USD 7,675 / GBP 5,120 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteLicense & copyright, Open access, Peer review
- License & copyright Copyright
Dermatology and Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative …
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Dermatology and Therapy, including information on fees, funding and licences, visit our Open access publishing page.
Source ↗Publisher website ·- Peer review Peer Review Process
Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive single-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Healthcare
- Country or region
- Germany
- Language
- English
- Frequency
- 12 issues per year
- Founded
- 2011
- ISSN
- 2193-8210
- Electronic ISSN
- 2190-9172
- Latest issue on the website
- Volume 16, Issue 9 (September 2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Dermatology and Therapy
What CAS zone is Dermatology and Therapy in?
In the 2025 upgraded edition of the CAS Journal Ranking, Dermatology and Therapy is in Zone 3 of Medicine, and in Zone 2 of the minor category Dermatology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Dermatology and Therapy?
The latest impact factor listed by LetPub is 4.61; CiteScore 7.3, h-index 72.
How long does peer review take at Dermatology and Therapy?
Based on the dates recorded on 120 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 61 days (interquartile range 41–79 days); authors report an average review time of about 6 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Dermatology and Therapy based?
Of the 140 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (40), Italy (28) and Spain (14). Counted from the institutions listed on the board page; for reference only.
Which databases index Dermatology and Therapy?
According to LetPub and DOAJ records, Dermatology and Therapy is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Embase and Current Contents; that list has not been checked against each database.
Is Dermatology and Therapy open access, and what is the APC?
Dermatology and Therapy is a fully open-access journal. APC about USD 7,675.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-28). Last updated: .